MTP836B - U-clavalenate/trihydrate formulations - Google Patents

U-clavalenate/trihydrate formulations

Info

Publication number
MTP836B
MTP836B MT836A MTP836A MTP836B MT P836 B MTP836 B MT P836B MT 836 A MT836 A MT 836A MT P836 A MTP836 A MT P836A MT P836 B MTP836 B MT P836B
Authority
MT
Malta
Prior art keywords
clavalenate
trihydrate
formulations
trihydrate formulations
Prior art date
Application number
MT836A
Other languages
English (en)
Inventor
Patrick John Crowley
Original Assignee
Beccham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MTP836(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beccham Group Ltd filed Critical Beccham Group Ltd
Publication of MTP836B publication Critical patent/MTP836B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MT836A 1977-10-11 1978-10-10 U-clavalenate/trihydrate formulations MTP836B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (1)

Publication Number Publication Date
MTP836B true MTP836B (en) 1979-05-11

Family

ID=10423254

Family Applications (1)

Application Number Title Priority Date Filing Date
MT836A MTP836B (en) 1977-10-11 1978-10-10 U-clavalenate/trihydrate formulations

Country Status (24)

Country Link
US (2) US4441609A (xx)
JP (1) JPS5476831A (xx)
AU (1) AU525089B2 (xx)
BE (1) BE870988A (xx)
CA (1) CA1105385A (xx)
CH (1) CH642258A5 (xx)
DE (1) DE2843318A1 (xx)
FR (1) FR2405711A1 (xx)
GB (1) GB2005538B (xx)
HK (1) HK73785A (xx)
IE (1) IE47450B1 (xx)
IL (1) IL55660A (xx)
IT (1) IT1109273B (xx)
JO (1) JO984B1 (xx)
KE (1) KE3525A (xx)
MT (1) MTP836B (xx)
MY (1) MY8500996A (xx)
NL (1) NL190631B (xx)
NZ (1) NZ188497A (xx)
PL (1) PL210174A1 (xx)
PT (1) PT68600A (xx)
SE (2) SE435899B (xx)
SG (1) SG34985G (xx)
ZA (1) ZA785682B (xx)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
SE421796B (sv) * 1975-02-07 1982-02-01 Glaxo Lab Ltd Forfarande for rening av klavulansyra och dess salter
DE2964817D1 (en) * 1978-09-06 1983-03-24 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
GR70283B (xx) * 1979-10-02 1982-09-03 Beecham Group Ltd
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (fr) * 1986-01-22 1988-12-23 Adir Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles.
ES2039226T3 (es) * 1986-12-30 1993-09-16 American Cyanamid Company Procedimiento para preparar composiciones que contienen policarbofil.
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
PL179210B1 (pl) * 1994-08-05 2000-08-31 Smithkline Beecham Plc Pojemnik z substancja wrazliwa na wilgoc PL PL PL PL
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
AR004510A1 (es) 1995-09-07 1998-12-16 Smithkline Beecham Plc Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
CA2280857A1 (en) * 1997-02-14 1998-08-20 Smithkline Beecham Laboratoires Pharmaceutiques Pharmaceutical formulations comprising amoxocyllin and clavulanate
AU1232500A (en) * 1998-10-30 2000-05-22 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
ATE518540T1 (de) * 1999-08-16 2011-08-15 Revaax Pharmaceuticals Llc Beta-lactam verbindung enthaltende neurotherapeutische zusammensetzung
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
AU2003254914A1 (en) * 2002-08-12 2004-03-03 Kyowa Hakko Kogyo Co., Ltd. Amino acid-containing chewable
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
US9458451B2 (en) 2007-06-21 2016-10-04 Gen-Probe Incorporated Multi-channel optical measurement instrument
KR20100101574A (ko) 2007-10-26 2010-09-17 렉산 파마슈티컬스, 인코포레이티드 클라불란산의 제약 제제
CN102413814A (zh) * 2009-04-29 2012-04-11 瑞恩药品公司 用于神经保护和治疗神经变性病症的克拉维酸类物质制剂
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions

Also Published As

Publication number Publication date
CH642258A5 (de) 1984-04-13
DE2843318A1 (de) 1979-04-12
GB2005538A (en) 1979-04-25
IE782019L (en) 1979-04-11
JPS6341886B2 (xx) 1988-08-19
IL55660A (en) 1981-09-13
PT68600A (en) 1978-10-01
IE47450B1 (en) 1984-03-21
SE8107592L (sv) 1981-12-17
ZA785682B (en) 1979-09-26
JO984B1 (en) 1979-12-01
SE435899B (sv) 1984-10-29
FR2405711A1 (fr) 1979-05-11
AU525089B2 (en) 1982-10-21
GB2005538B (en) 1982-05-26
US4301149A (en) 1981-11-17
JPS5476831A (en) 1979-06-19
CA1105385A (en) 1981-07-21
SE7810591L (sv) 1979-04-12
BE870988A (fr) 1979-04-03
NL7810176A (nl) 1979-04-17
AU4050678A (en) 1980-04-17
PL210174A1 (xx) 1980-08-11
HK73785A (en) 1985-10-04
FR2405711B1 (xx) 1982-10-29
MY8500996A (en) 1985-12-31
US4441609A (en) 1984-04-10
IT1109273B (it) 1985-12-16
SE451668B (sv) 1987-10-26
SG34985G (en) 1985-11-15
IT7851415A0 (it) 1978-10-09
IL55660A0 (en) 1978-12-17
NZ188497A (en) 1981-05-01
KE3525A (en) 1985-05-31
NL190631B (nl) 1994-01-03

Similar Documents

Publication Publication Date Title
MTP836B (en) U-clavalenate/trihydrate formulations
GB2010944B (en) Sound-absorbingstructures
JPS545117A (en) Turboofeeder
AU4201478A (en) Step-stools
GB2005266A (en) 4-amino-4-arylcyclohexanols
GB2005799A (en) Airsprings
JPS5459291A (en) Sulphoneamide
HK13681A (en) Pyridobenzodiazepines
GB2005664A (en) 6-deoxyneamines
AU3828478A (en) Benzodiazepine-diones
GB2002751A (en) Imidazo-isoquinoline-diones
GB2005971B (en) Tailers
GB1556977A (en) Psrayer
CS541878A1 (en) Zpusob vyroby tricyklickych derivatu pyrimidinu
GB2009167B (en) Benzoxazolyl-phenyl-stilbenes
GB2003498A (en) Chrome-tanning
AU3533578A (en) Micro-mill-mixer
JPS53116372A (en) Steroidspirooxazolidine
IL52121A0 (en) Polyvinylbenzylamine
BG28612A1 (en) Auto- train
AU3939978A (en) 2-guanidinomethyl-indoline
JPS53135031A (en) Fauset
AU4076678A (en) Nd catalystused therein
JPS53105497A (en) Triazoloothienoodiazepinee11one
GB2006766A (en) Ureidonitriles